VitalCare Signs LOI for Diabetes Treatment Centers in Indiana: VitalCare Will Open Center in Peru, Indiana for Diabetes Wound Care VitalCare Diabetes Treatment Centers, Inc. (Pink Sheets:VDTI), a Nevada corporation, today announced they have signed a letter of intent to open two new Diabetes Treatment and Wound Care Centers in Indiana. The centers will be administering the FDA approved iCAT treatment for diabetes and related wound care for Type 1 and Type 2 diabetes patients. These are the first of a series of centers to be opened in the Midwest of the United States. - 2008-04-29

VitalCare Signs LOI For Diabetes Treatment Center In Utah: Center Will Provide iCAT Therapy for Type 1 and Type 2 Diabetics VitalCare Diabetes Treatment Centers, Inc. (Pink Sheets:VDTI) a Nevada corporation, today announced they have signed a letter of intent to establish a joint-venture relationship with South Valley Inpulse Center, LLC, an existing Diabetes Treatment Center in Draper, Utah. The center will be administering the FDA approved iCAT treatment for Type 1 and Type 2 diabetes patients. - 2008-04-28

VitalCare Offers Licenses for Diabetes Treatment Centers: Company Will Offer Licenses in Selected Markets to Qualified Professionals VitalCare Diabetes Treatment Centers, Inc. (Pink Sheets:VDTI), a Nevada corporation, today announced it will offer licenses in select markets for Diabetes Treatment Centers. - 2008-04-24

VitalCare Announces National Launch of Diabetes Treatment Centers: National Launch of FDA Approved iCAT Therapy Begins VitalCare Diabetes Treatment Centers, Inc. (Pink Sheets: VDTI), a Nevada Corporation, today announced the national launch for opening licensed diabetes treatment centers utilizing the micro-dose intravenous insulin pump technology together with proprietary algorithms and clinical protocols for providing Intercellular Activation Therapy (iCAT) for treating diabetes. - 2008-04-22

VitalCare Announces FDA Approval of Infusion Device Used for iCAT Therapy: National Announcement of FDA Approved Infusion Technology VitalCare Diabetes Treatment Centers, Inc. (NASDAQ: VDTI), a Nevada Corporation, today announced the FDA approval (called allowance to market) exists for the infusion devices used by VitalCare for its Intracellular Activation Therapy (iCAT) treatment of Type 1 and Type 2 diabetes. Jimmy McDougald, CEO stated, stated, "This is a major factor in the establishment of our treatment centers, as we begin to move iCAT into the commercial market." - 2008-04-21

Charming New Children's Book Proves that Bigger is Not Always Better Madam's Mini by Jeff E. Lucier is an enchanting children's book set against the world of classic cars. - 2008-01-24

Paversearch.com Releases an Extensive Guide to Permeable Pavers Paversearch, Inc has released an extensive guide to Permeable Pavers. - 2007-08-30

Risk Solver(TM) is First New 'Industrial Strength' Monte Carlo Simulation Tool for Excel in 15 Years Frontline Systems, developer of the Excel Solver and leading-edge optimization software, is now offering leading-edge simulation software for Excel with its newly released Risk Solver(TM), a tool for risk analysis of business models using high-speed, fully interactive Monte Carlo simulation. Prospective users can download a free trial version at www.solver.com. - 2007-04-28

1